Genmab A/S
NASDAQ:GMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
NASDAQ:GMAB
|
DK |
|
F
|
Fomento Economico Mexicano SAB de CV
F:FOMA
|
MX |
|
A
|
Asta Co Ltd
KOSDAQ:246720
|
KR |
|
Riso Kyoiku Group Corp
TSE:4714
|
JP |
|
High Templar Tech Ltd
NYSE:HTT
|
CN |
|
H
|
Hua Hsuan Real Estate Co Ltd
TPEX:2740
|
TW |
|
F
|
FamiCord AG
OTC:VTIAF
|
DE |
|
Martin Midstream Partners LP
NASDAQ:MMLP
|
US |
|
I
|
Intesa Sanpaolo SpA
DUS:IES
|
IT |
|
P
|
Papoutsanis Industrial and Commercial of Consumer Goods SA
ATHEX:PAP
|
GR |
|
Hotai Motor Co Ltd
TWSE:2207
|
TW |
|
P
|
Pryce Corp
XPHS:PPC
|
PH |
|
D
|
Dover Corp
SWB:DOV
|
US |
Bankruptcy Probability
Genmab A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genmab A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
144.7B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genmab A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genmab A/S has total debt of 5B USD. This includes both short-term (0 USD) and long-term (5B USD) debt.
You can find a full breakdown on its Balance Sheet.